| Trial ID: | L3853 |
| Source ID: | NCT00130481
|
| Associated Drug: |
Atorvastatin 20 Mg Daily For 3 Months
|
| Title: |
Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Atorvastatin 20 mg daily for 3 months
|
| Outcome Measures: |
Primary: Augmentation Index (arterial stiffness)|ENDO-PAT (Peripheral Arterial Tone) score (endothelial function)|Low density lipoprotein | Secondary: Urine microalbumin|Pubertal stage|Body mass index (BMI)|Blood pressure|Glycated hemoglobin (HbA1c)
|
| Sponsor/Collaborators: |
Sponsor: University of Florida
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: PREVENTION
|
| Start Date: |
2005-04
|
| Completion Date: |
2007-04
|
| Results First Posted: |
|
| Last Update Posted: |
2012-03-07
|
| Locations: |
University of Florida, Gainesville, Florida, 32610, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00130481
|
